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Zusammenfassung 
I 
Zusammenfassung 
Die chronisch obstruktive Lungenerkrankung (COPD) und die akute Lungen-
schädigung/akutes Lungenversagen (ARDS) sind Erkrankungen, die aufgrund ihrer 
Kortikosteroidresistenz durch hohe Mortalitätsraten gekennzeichnet sind. Für das 
Verständnis der zugrunde liegenden immunologischen und toxikologischen 
Mechanismen ist die Entwicklung humanrelevanter präklinischer in vivo- und in vitro-
Modelle von hoher Dringlichkeit. Ziel dieser Arbeit war es, ein Modell zu etablieren, 
das die Immunantwort in COPD und die vorrangig toxischen Aspekte der akuten 
Lungenschädigung/ARDS widerspiegeln kann. Dazu wurde die organtypische 
Gewebekultur Präzisionslungenschnitte (PCLS) mit den Modellsubstanzen 
Lipopolysaccharid (LPS), Ozon (O3) und Stickstoffdioxid (NO2) exponiert. 
Die Stimulation humaner PCLS mit dem Toll-like-Rezeptor-4 (TLR4) Agonist LPS 
aktivierte das angeborene Immunsystem und induzierte eine pro-inflammatorische 
Immunantwort, wie sie in COPD-Patienten beschrieben wird. Zytokine wie z. B. IL-1β, 
MCP-1 und GM-CSF zeigten einen signifikanten Anstieg, der durch das synthetische 
Kortikosteroid Dexamethason inhibiert werden konnte. Dagegen bewirkte eine akute 
Exposition mit hohen Dosen O3 und NO2 vorrangig eine Schädigung des Gewebes, wie 
sie bei akuter Lungenschädigung/ARDS auftritt. Eine pro-inflammatorische 
Immunantwort konnte nicht gezeigt werden. Zytokine wie IL-12, Eotaxin, MCP-1 oder 
MIP-1β blieben nahezu unverändert und ein Anstieg konnte lediglich für IL-1α nach 
O3-Exposition nachgewiesen werden. 
Damit konnte abschließend gezeigt werden, dass PCLS ein geeignetes Model sind, um 
die Immunantwort in COPD und die Gewebetoxizität in akuter 
Lungenschädigung/ARDS als Teilaspekte dieser Erkrankungen darzustellen. 
Abstract 
II 
Abstract 
Severe lung diseases including chronic obstructive pulmonary disease (COPD) and 
acute lung injury/acute respiratory distress syndrome (ARDS) result in high mortality 
rates with resistance to nearly all anti-inflammatory therapies. To understand the 
underlying immunological and toxicological mechanisms the need emerged to develop 
adequate preclinical in vivo and in vitro models that extrapolate the human in vivo 
situation. The aim of these studies was to provide a model reflecting the immune 
responses in COPD and reflecting the toxicological events occurring in acute lung 
injury/ARDS. For that, widely used model compounds lipopolysaccharide (LPS), ozone 
(O3), and nitrogen dioxide (NO2) were added to the organotypic tissue culture model 
precision-cut lung slices (PCLS). 
Treatment of human PCLS with the toll-like receptor 4 (TLR4) agonist LPS activated 
the innate immunity resulting in a pro-inflammatory cytokine profile similar to that in 
COPD patients. Cytokines such as IL-1β, MCP-1, and GM-CSF were significantly 
increased and could be inhibited by co-treatment with the synthetic corticosteroid 
dexamethasone. In contrast, air-liquid interface (ALI) exposure of PCLS to the reactive 
gas compounds O3 and NO2 induced damage of lung parenchyma – described as a main 
feature in acute lung injury/ARDS. However, the pro-inflammatory immune response 
was not prominent. Cytokines such as IL-12, eotaxin, MCP-1, and MIP-1β remained 
unchanged. IL-1α expression was only increased upon O3 exposure.  
Concluding it could be shown that PCLS represent a suitable model to reflect immune 
responses in COPD, respectively tissue damage in acute lung injury.
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Preamble 
This cumulative doctoral thesis was prepared at the Fraunhofer Institute for Toxicology 
and Experimental Medicine (ITEM) in the Department of Immunology, Allergology 
and Immunotoxicology under the supervision of PD Dr. Armin Braun and Dr. Katherina 
Sewald. The experiments with precision-cut lung slices (PCLS) were mainly performed 
in the Department of Immunology, Allergology and Immunotoxicology. Human lung 
tissue for the preparation was obtained in cooperation with Klinikum Region Hannover. 
The air-liquid interface (ALI) exposure model was implemented in cooperation with the 
Department of In Vitro Toxicology of the Fraunhofer ITEM. Ex vivo experiments were 
performed to evaluate the potential of PCLS to reflect the immune response described in 
COPD and the acute lung damage occurring in acute lung injury/ARDS. 
 
The present work refers to the following publications: 
 
 
Switalla S., Lauenstein L., Prenzler F., Knothe S., Förster C., Fieguth H.-G., Pfennig 
O., Schaumann F., Martin C., Guzman C. A., Ebensen T., Muller M., Hohlfeld J.M., 
Krug N., Braun A., Sewald K.  
"Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices".  
Toxicol Appl Pharmacol. 2010. April 29; Epub ahead of print 
 
 
Switalla S., Knebel J., Ritter D., Krug N., Braun A., Sewald K.  
"Effects of acute in vitro exposure of murine precision-cut lung slices to gaseous 
nitrogen dioxide and ozone in an air-liquid interface (ALI) culture".  
Toxicol Letters. 2010. Jul 1; 196: 117-124 
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1 Introduction 
This doctoral thesis describes the use of PCLS as a model to reflect the immunological 
and toxicological responses described in the lung diseases COPD and acute lung 
injury/ARDS, respectively. For that, widely used model compounds LPS, NO2, and O3 
were used. Special emphasis was placed on the induction of cytotoxic or pro-
inflammatory responses, which finally were compared to in vitro and in vivo data. 
 
1.1 Homeostasis of the lung 
1.1.1 Interplay of resident and migrating cell types under homeostasis 
The lung plays a pivotal role in gas exchange. It is lined by a monolayer of epithelial 
cells with a surface of approximately 70 m2 in adults. Each minute, 6-7.5 L of air are 
inhaled (Holt et al., 2008). The elaborate branching network of airways with its 
extensive surface area is directly connected to the external environment. It is thus 
possible that inhaled molecules may pass the thin air-blood barrier and can rapidly be 
absorbed into the systemic circulation. This renders the lung also to a portal of entry 
into the body for a multitude of potentially harmful environmental agents (Patton and 
Byron, 2007). These inhaled agents comprise chemicals like irritant gases or agents of 
biological origin. The latter include dangerous infectious particles such as bacteria, 
viruses, and fungi, and non-infectious particles such as allergens, plant pollen, and 
animal dander (Hammad and Lambrecht, 2008). Keeping the local respiratory 
homeostasis is a sophisticated challenge for the organism. It involves maintenance of 
the integrity of the mucosal epithelial barrier and the immunological balance. In 
particular, cells of the immune system such as macrophages and dendritic cells (DCs), 
but also structural cells like epithelial or endothelial cells fulfil these requirements, to 
protect the lung from noxious agents and preserve the function of the organ. 
Epithelial and endothelial cells are resident structural cells that are no typical effector 
cells of the innate immunity; but they contribute to microbial defense mechanisms by 
their barrier function. They form a paracellular barrier via tight junctions, thereby 
preventing agents and pathogens from entering the body or the systemic circulation as 
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applied to endothelium. Upon inhalation and successful colonization of pathogens 
which is followed by disturbance of the homeostasis, epithelial type II pneumocytes 
support inflammatory responses by the secretion of cytotoxic and anti-microbial factors. 
These include surfactant proteins and lysosomes or reactive oxygen species (ROS) 
(Kinnula et al., 1992; Suzuki et al., 2008). The important role of the epithelium for the 
interplay and for modulating the activity of adjacent cell populations can be seen, e.g., 
in the secretion of the cytokine IFN, which amplifies the host response to infectious 
particles. Produced growth factors such as granulocyte colony-stimulating factor (G-
CSF) and granulocyte/macrophage colony-stimulating factor (GM-CSF) improve local 
survival of neutrophils and regulate DC and B cell functions (Bleck et al., 2006; Cox et 
al., 1992; Kato et al., 2006). Other mechanisms are used by resident endothelial cells: 
They reorganize their cytoskeleton and alter the expression of surface molecules such as 
E- and P-selectins or integrins such as Leukocyte Function-Associated Antigen-1 (LFA-
1) and Very-Late Antigen-4 (VLA-4) to actively regulate the immigration of, e.g., 
leukocytes and the re-establishment of homeostasis. Common to both epithelial and 
endothelial cells is the production of cytokines and chemokines in response to external 
stimuli. Depending on the stimulus, the pro-inflammatory cytokines tumor necrosis 
factor-α (TNF-α) and interleukin-1α (IL-1α) as well as chemokines such as MIP-1/2, 
RANTES, or IL-8 are released (Suzuki et al., 2008). The latter are responsible for the 
chemoattraction of migrating monocytes and lymphocytes (Bless et al., 2000). 
The function of the epithelium and the endothelium to prevent invasion of inhaled 
agents is supported by resident but also migrating immune cells belonging to the innate 
immunity and regulating the primary immunological balance. These are leukocytes 
including macrophages and DCs which link the innate and the adaptive immunity. They 
possess the capability of regulating immune responses by, e.g., production of pro- and 
anti-inflammatory cytokines thus balancing lung homeostasis. Both cell types are 
located in interstitial tissues and alveolar spaces. Macrophages are mainly located on 
mucosal surfaces whereas DCs are below mucosal surfaces (Lohmann-Matthes et al., 
1994; Veres et al., 2009). Here, alveolar macrophages phagocyte microbial components, 
particles, and cellular debris, and secrete proteases or ROS due to activation (MacNee, 
2001; Russel et al., 2002). The activation of macrophages is furthermore supported by 
the direct interaction with epithelial cells (Frank et al., 2006). Beneath epithelial 
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surfaces, DCs take up antigens which have succeeded in passing the epithelial barrier 
and present them by major histocompatibility complex (MHC) class II molecules to 
naïve T cells in the lymph nodes, thereby activating the adaptive immunity. However 
immature DCs also contribute to lung homeostasis by identifying pathogenic 
components. A viral infection e.g. results in the destruction of infected cells by natural 
killer (NK) cells. The resulting production of type I IFNs leads to activation of 
surrounding cells such as epithelial cells. In this context, DCs support the defense 
mechanisms by recognition of viral nucleotides due to TLR3 ligation. The crosstalk 
between NK cells and maturing DCs results in an activation and cytokine production by 
both cell types, including NK cell proliferation and further DC maturation (Gerosa et 
al., 2002). Macrophages and DCs both secrete pro-inflammatory mediators such as 
TNF-α and IL-1β as well as chemokines such as monocyte chemotactic protein-1 
(MCP-1) or MIP-1. These chemoattractants induce the recruitment of cells responsible 
for the second phase of the immune response such as neutrophils, NK cells, and 
monocytes, but additionally support activation of epithelial and endothelial cells (Clark 
et al., 2000). The release of IL-10 mediates an opposing anti-inflammatory effect which 
regulates the balance of pro- and anti-inflammatory cytokines, thus preventing tissue 
injury (Ogawa et al., 2008).  
An imbalance between pro- and anti-inflammatory mediators can be the result of acute 
but also chronic exposure to biological or chemical agents including irritating gas 
compounds or cigarette smoke. This disturbed homeostasis is a feature of lung diseases 
like chronic obstructive pulmonary disease (COPD) and acute lung injury/acute 
respiratory distress syndrome (ARDS). 
 
1.2 Disturbance of homeostasis in the respiratory tract leads to 
the severe lung diseases COPD and acute lung injury/ARDS 
1.2.1 Permanent inhalation of the main risk factor cigarette smoke can lead 
to COPD 
Chronic obstructive pulmonary disease (COPD) is a complex inflammatory lung disease 
that has become a major and increasing global health problem. It is currently ranked as 
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the sixth leading cause of mortality worldwide (Barnes, 2007; Rabe et al., 2007). 
According to published data of the World Health Organization WHO, approximately 
210 million people suffer from COPD. As a consequence of this an estimated 3 million 
died of the disease in 2005. In developed countries, COPD is mainly induced by 
smoking; other risk factors include occupational exposure, air pollution, and especially 
in developing countries exposure to biomass fuels (Smith, 2000, Barnes et al., 2003). 
The disease is characterized by clinical and pathological outcomes such as chronic 
obstructive bronchiolitis, emphysema, and irreversible airflow limitation. Multiple 
mediators and inflammatory cells are involved and orchestrate the development of the 
disease. Regarding the immunological aspects of COPD, they differ between the four 
stages that were defined by the Global Initiative for Chronic Obstructive Lung Disease 
(GOLD). The early stage I is characterized by the generation of oxidative stress 
including, e.g., superoxide anions (O2 −) and hydrogen peroxide (H2O2) (Barnes, 2004; 
Rahman et al., 1996). Occurring breakdown of connective tissue mainly affects 
epithelial and endothelial cells. Degradation products such as hyaluronate and biglycan 
are generated and activate macrophages as well as DCs through TLR2/4 ligation. 
Subsequently, inflammatory mediators such as MCP-1, TNF-α, IL-1β, GM-CSF, and 
IL-8 are released (Barnes et al., 2003; Barnes, 2004; Cosio et al., 2009). The early stage 
is followed by the stage II, which is characterized by DC-mediated activation of CD8+ T 
cells and TH1 cells. DCs release IL-12 which induces STAT-4-dependent production of 
IFN-γ in CD4+ T cells. The amount of activated T cells correlates with the degree of 
airflow limitation in COPD. CD8+ cytotoxic T cells are the predominant cells in the 
chronic stages III and IV. Their presence correlates with the number of apoptotic cells 
and the degree of emphysema and airflow obstruction (Cosio et al., 2009). In these 
stages, cells die of necrosis and apoptosis induced by the release of proteolytic enzymes 
such as perforin or granzymes A and B (Chrysofakis et al., 2004; Lieberman, 2003). 
The chronic pulmonary inflammation also implies in systemic effects. These include 
loss of muscle function and muscle mass, especially in the progressive course of the 
disease. Furthermore, an increased number of neutrophils and activated leukocytes as 
well as increased cytokine production can be detected in the peripheral blood (Oudijk et 
al., 2003).  
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1.2.2 Widely used model compounds such as LPS and cigarette smoke 
mimic COPD in animal and cell-based models 
Substantial knowledge of the clinical and pathological outcomes of the disease and its 
progression has been obtained from studies with COPD patients (Dekhuijzen et al., 
1996; Dentener et al., 2001; Tumkaya et al., 2007). Thereby, the impact of the disturbed 
balance between oxidants and antioxidants with regard to the development of 
emphysema has been demonstrated (Dekhuijzen et al., 1996). In particular, the released 
oxidants O2 − and H2O2 exceeded the amounts of endogenous enzymatic antioxidants 
such as catalase, superoxide dismutase (SOD), and glutathione peroxidase (Barnes, 
2004). Anti-inflammatory corticosteroids, however, were ineffective in redressing 
homeostasis and in protecting the lung from disruption (Culpitt et al., 1999). 
These clinical and pathological outcomes are the basis of most experimental exposure 
models that are performed in animals such as rats (Lee et al., 2005), rabbits (Terashima 
et al., 1997), guinea pigs (Wright and Churg, 1990), monkeys (Plopper and Hyde, 
2008), and mice (Shapiro et al., 2003). Different components are being used to elicit 
parts of the disease: e.g., tissue-grading enzymes such as papain or neutrophil elastase 
(Fox and Fitzgerald, 2009; Stone et al., 1993), coal mine dust (Coggon and Newman, 
1998), lipopolysaccharide (LPS) (Brass et al., 2008), and, most importantly, cigarette 
smoke. Chronic exposure (> 6 months) of mice and guinea pigs to cigarette smoke 
produces lesions that morphologically resemble human emphysema of the chronic 
stages III and IV (Shapiro et al., 2003; Wright and Churg, 1990). The same lesions 
could be generated by instillation of the plant protease papain, human neutrophil 
elastase, and LPS (Brass et al., 2008; Fox and Fitzgerald, 2009). Systemic outcomes 
such as an increased number of granulocytes in the blood or stimulated bone marrow 
that are similar to those in humans could be shown in rabbits in response to cigarette 
smoke (Terashima et al., 1997). The direct comparison of LPS-induced human COPD 
models to animal models revealed that in both humans and animals, an inflammatory 
response is evoked (Hohlfeld et al., 2007; Vernooy et al., 2002). Although cell types or 
the magnitude of effects differed, pro-inflammatory cytokines such as TNF-α, IL-6, or 
IL-18, which are present, e.g., in the early stage I, were released in all these models 
(Hohlfeld et al., 2008; Jagielo et al., 1996; Vernooy et al., 2002). 
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The background of the cigarette smoke-induced cytokine production, especially the 
influence of mitogen-activated protein kinase (MAPK) or the transcription factors 
activating protein-1 (AP-1), extracellular signal-regulated protein kinase ERK1/2, and 
NF-κB, was additionally elucidated in cell culture models. In particular, THP-1 cells, 
DCs, human lung macrophages, and bronchial as well as alveolar epithelial cells were 
investigated (Birrell et al., 2008; Demirjian et al., 2006; Hellermann et al., 2002, 
Vassallo et al., 2005). In isolated macrophages and parenchymal explants directly 
received from COPD patients the immune responses regarding expression of IL-1, 
TNF-α, IL-5, GM-CSF, and IL-10 upon LPS and dexamethasone treatment were 
analyzed (Culpitt et al., 2003; Hackett et al., 2008). Unresponsiveness to 
dexamethasone in alveolar macrophages from COPD patients, as it is known in patients, 
could be confirmed. Furthermore, a reduced ability to respond to stimuli, killing of 
bacteria, and phagocytosis was found (King, Jr. et al., 1988). 
In all above mentioned studies on COPD, it became clear that it is a disease which is 
based on a chronic pro-inflammatory immune response regulated by the interplay of 
immune cells. In cell cultures it is nearly impossible to investigate immune reactions 
that are predicated on cell interactions. However, these interactions and the 
physiological structure can be displayed in 3D lung tissue culture models which 
comprise all cell types of the respiratory tract. Such models additionally offer the 
possibility to study toxic events occurring, e.g., in lung diseases that are mainly 
characterized by an acute toxicological response with a diffuse uncoordinated 
inflammatory response in the background. These lung diseases are acute lung injury and 
ARDS. 
 
1.2.3 High-dose exposure to chemicals and toxic agents leads to acute lung 
injury/ARDS 
Acute lung injury or the severe form ARDS are lung diseases characterized by 
devastating disorders of the pulmonary immune system. In these diseases, a diffuse 
damage to pulmonary parenchyma occurs within hours to days. Responsible insults are 
divided into direct and indirect insults. Direct insults comprise high-dose exposure to 
chemicals, inhalation of toxic drugs or smoke. Indirect or extra-pulmonary insults 
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include severe sepsis, acute pancreatitis, and trauma (Tsushima et al., 2009; Wang et 
al., 2008). In the USA, an estimated 190,000 cases are described each year with an in-
hospital mortality of approximately 40% (Rubenfeld et al., 2005). The main causes of 
the high mortality rate are emerging systemic disorders such as systemic inflammatory 
response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), or multiple 
organ failure (MOF). A common feature of all forms of acute lung injury and ARDS is 
increased alveolar membrane permeability owing to endothelial and epithelial 
disruption and a diffuse inflammation in the pulmonary parenchyma.  
In general, the disease is characterized by two major phases: the acute exudative phase 
and the later fibroproliferative phase. The exudative phase occurs within 12-72 hours 
and is associated with edema and increased permeability in endothelial cells and type I 
pneumocytes. Consequently, the structural barrier is lost, resulting e.g. in an electrolyte 
imbalance. Multiple pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF-α 
and ROS are released, surfactant activity is impaired by the disruption of type II 
pneumocytes, and the blood flow is disturbed by thrombus formation leading to 
hypoxemia. In the fibroproliferative phase, fibroblasts proliferate and differentiate, 
arteries are destructed, and finally consolidation and fibrosis of the pulmonary 
parenchyma become apparent (Tsushima et al., 2009). 
 
1.2.4 Model compounds LPS and irritant gases O3 and NO2 mimic acute 
lung injury/ARDS in animal and cell-based models 
Human in vivo studies performed with LPS as a main inducer of acute lung 
injury/ARDS are critical, especially with regard to arising systemic disorders 
(Andreasen et al., 2008). For this reason, the study of endotoxin-induced inflammation 
and lung injury in humans is limited to few models. Administration of endotoxin into 
the whole lung was used to study pulmonary function (Michel et al., 1997; Rylander et 
al., 1989). Intrapulmonary local segmental challenges with LPS made it possible to 
determine local lung inflammation by quantifying immigrated cells such as neutrophils 
and pro-inflammatory cytokines such as IL-1β, TNF-α, IL-8, and G-CSF (O´Grady et 
al., 2001). Similar results were obtained after intravenous administration of low-dose 
LPS. Low-grade systemic inflammation indicated by increased release of pro-
Introduction 
9 
inflammatory cytokines could be measured (Erikstrup et al., 2006; Starkie et al., 2003), 
but the application of higher doses of LPS was too critical so that severe sepsis could 
not be imitated. Besides LPS, further direct insults such as ozone were administered to 
assess induced lung injury and impaired pulmonary function in humans (Samet et al., 
2001). 
Given the inadequacy of human models, multiple models of acute lung injury and 
ARDS as well as endotoxemia models for systemic inflammation were generated in 
mice, rats, pigs, hamsters, sheeps, and rabbits (Beutler et al., 2008; Doherty et al., 1992; 
Gonzalez et al., 1996; Heinzel et al., 1994; Howard et al., 1993; Meulenbelt et al., 
1994; Peng et al., 2004). In most cases, LPS was used to elicit a similar phenotype of 
the disease, but additionally further direct insults such as acid, oleic acid, bleomycin, 
saline lavages, or the irritant gases ozone (O3) and nitrogen dioxide (NO2) were applied 
(Januszkiewicz and Mayorga, 1994; Kenyon et al., 2002; Lehnert et al., 1994; Matute-
Bello et al., 2008). 
The above mentioned insults have been selected to reflect local and systemic features of 
acute lung injury/ARDS. While acids disrupt the alveolar barrier accompanied by 
neutrophil infiltration, bleomycin causes inflammatory injury and fibrosis (Matute-Bello 
et al., 2008). LPS-induced acute lung injury/ARDS models allow the investigation of 
pulmonary hypertension, changes in dynamic pulmonary compliance, and pulmonary 
edema (Gonzalez et al., 1996). Microvascular permeability based on disruption of the 
epithelial and endothelial barriers and inflammation were studied after 6 and 24 hours, 
time points that play an important role in the exudative phase of the disease (Peng et al., 
2004). Additionally released cytokines such as IL-1β, TNF-α, MCP-1, and IL-8 have 
high relevance in acute lung injury (Bao et al., 2010; Xu et al., 2010). O3-/NO2-based 
acute lung injury/ARDS models were used to investigate time courses of cells such as 
macrophages or neutrophils, edema, epithelial cell damage, the role of inducible nitric 
oxide synthase, and imbalanced glutathione metabolism (Bassett et al., 1988; 
Hochscheid et al., 2005; Kenyon et al., 2002; McElroy et al., 1997). Inhalation of very 
high and toxic amounts (up to 250 ppm) of NO2 gave insight into the dependence and 
balance between exposure concentrations and exposure time in lung injury and 
development of edema (Lehnert et al., 1994). Systemic outcomes including multiple 
organ failure and multiple organ dysfunction have mostly been investigated in animal 
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models of endotoxemia (Angelova et al., 2004; Beutler et al., 2008). In these studies, 
the role of cytokines such as IFN-γ, TNF-α, and IL-10, or the chemokines MCP-1 and 
RANTES in systemic inflammation were investigated during lethal LPS-induced 
endotoxemia (Angelova et al., 2004; Heinzel et al., 1994; Howard et al., 1993; 
Wysocka et al., 1995). 
The importance of the occurring endothelial and epithelial barrier disruption as well as 
the production of cytokines and proliferation of fibroblasts in the progression of the 
disease is incontestable. Therefore, the underlying mechanisms have been investigated 
in in vitro models including alveolar epithelial cells, macrophages, and neutrophils 
(Geiser, 2003; Geiser et al., 2004; Jacobson, 2009; McVerry and Garcia, 2005; Perkins 
et al., 2007; Yin et al., 2010). In one of these studies, alveolar epithelial repair 
mechanisms were investigated in an in vitro model of wound repair using A549 cells 
and lung distal epithelial cells in the presence of oxidative stress (Geiser et al., 2004). 
Actin cytoskeletal rearrangement and cell signaling were shown to be influenced in 
endothelial cells (Jacobson, 2009; McVerry and Garcia, 2005) and activated 
macrophages were implicated to modulate inflammatory immune responses by 
production of TNF-α or macrophage migration inhibitory factor (MIF4) (Yin et al., 
2010). 
Understanding the underlying mechanisms to avoid the generation of apoptotic and 
necrotic cells as well as an inflammatory response can eventually prevent systemic 
disorders, organ failure, and death (Lucas et al., 2009). These mechanisms have been 
comprehensively studied in the presented in vivo and in vitro models to reflect COPD 
and acute lung injury/ARDS stages. In vivo animal models, however, lack human 
physiology, and human models are ethically unacceptable because of the systemic 
outcomes. In vitro models furthermore lack organ complexity, resulting in the use of 
organ-based tissue cultures. 
 
Introduction 
11 
1.3 PCLS combine organ complexity and human relevance in an 
ex vivo lung model 
The limited value and inadequacy of current in vivo and in vitro lung models have led to 
an augmented use of tissue cultures during the last years. Major limitations concerning 
the suitability of a model already begin with the structure of the lung. Laboratory 
animals, in particular rodents, display essential differences in structure such as missing 
respiratory bronchioles or thickness of the epithelium, which is only one fifth that of 
humans (Plopper and Hyde, 2008). In addition, life expectancies are low (for rodents an 
average of 2 years), making it difficult to reflect lung diseases that need to develop over 
many years such as COPD. Furthermore, limitation of cell lines is the reflection of 
immune responses that are based on one single cell type. While the human bronchial 
epithelial cell line BEAS-2B release chemokines or growth factors such as MIP-3α or 
GM-CSF in response to LPS (Sha et al., 2004), DCs produce T cell polarizing cytokines 
such as IL-12 or IFN-γ (van Riet et al., 2009). Organotypic cultures thus offer the 
unique possibility to overcome some of these discrepancies and to investigate organ-
specific effects in a three-dimensional (3D) model (MacGregor et al., 2001). 
Precision-cut lung slices (PCLS) constitute an organotypic tissue culture model that 
consists of all cell types of the respiratory tract. Basically all PCLS consist of the same 
cell types. But the exact composition of lung cells in PCLS mainly depends on the 
species. Human PCLS contain cells of non-respiratory and respiratory bronchioli which 
start at the fourth generation of the bronchial tree and additionally of the surrounding 
alveoli. Bronchi can not be prepared because of their dimension. In contrast, rodent 
lungs can be prepared completely due to their small dimension. Thus, PCLS start at the 
first generation of the bronchial tree and are composed of lobar and segmental bronchi, 
non-respiratory bronchioli, and alveoli. The alveolar epithelium is formed by type I and 
type II pneumocytes. Type I pneumocytes are mainly responsible for gas exchange and 
type II pneumocytes produce surfactant. The alveoli are separated by thin septa 
interalveolari that contain a compact network of capillaries, fibers of collagen, 
fibroblasts, leukocytes, mast cells, macrophages, DCs, contractile cells, and nerve 
fibers. In PCLS all these cells are situated in their physiological arrangement, thereby 
reflecting the functionality and morphology of the intact organ. Further differences in 
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the existing cell types but also in the states of activation between, e.g., humans and mice 
are mainly based on their contact to external antigens. In this context, humans who 
constantly inhale antigens possess additional immune cells in the respiratory tract, such 
as memory T and B cells that are lacking in naïve mice. 
The method of preparing precise organ slices was initially developed in 1980 by 
Krumdieck et al., who for the first time used a special microtome (Krumdieck et al., 
1980). In the 90s, Martin et al. refined the method and succeeded in generating very 
thin slices with a constant thickness of approximately 250 ± 20 µm without loss of 
viability, with high precision, and high reproducibility (Martin et al., 1996). The low 
variability is mainly based on the fact that internal controls can be performed within one 
animal, which furthermore reduces the number of required animals and subsequently 
confirms the requirements for an alternative method. In the following years, the 
technique was established for a wide range of species such as rat, mouse, guinea pig, 
primate, and human (Bergner and Sanderson, 2002b; Cooper and Panettieri, Jr., 2008; 
Henjakovic et al., 2008; Ressmeyer et al., 2006; Joad et al., 2009), but also for a variety 
of different organs such as liver, kidney, heart, and lung (Bergner and Sanderson, 
2002a; De Kanter et al., 2004; Pushparajah et al., 2008). Vital lung slices were used for 
microscopic observations to investigate in particular functional responses of the airways 
and their contribution to outcomes of sensitization. For this purpose, 
bronchoconstriction as an early allergic response was determined after treatment of 
passively sensitized lung slices with different stimuli (Wohlsen et al., 2001; Wohlsen et 
al., 2003; Cooper et al., 2009). The combination of bronchial contractility and calcium 
signaling was analyzed in slices with a thickness of 75 µm after addition of adenosine 
triphosphate (ATP) or acetylcholine (Bergner and Sanderson, 2002a; Bergner and 
Sanderson, 2002b). Close to the use of PCLS in pharmacological studies (Moreno et al., 
2006; Nassimi et al. 2009; Sturton et al., 2008), evaluation of the biological response of 
PCLS to toxic chemicals has frequently been described. Xenobiotics-mediated 
metabolism and detoxification mechanisms have been evaluated in response to diesel 
exhaust particles, aroclor 1254, fuel, acrolein, solid lipid nanoparticles, and paraquat 
(Hays et al., 2003; Lake et al., 2003; Le Prieur et al., 2000; Monteil et al., 1999; Morin 
et al., 1999; Nassimi et al., 2009; Price et al., 1995). Others have reported the use of 
lung slices for several infection studies with viruses and bacteria to obtain insights into 
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inflammatory processes or cytopathic effects (Chakrabarty et al., 2007; Goris et al., 
2009).  
For all the above mentioned approaches, PCLS display a suitable model to study 
immunological and toxicological issues in a tissue culture. The preservation of the 
pulmonary structure in PCLS and the possibility to generate lung slices from nearly all 
species, including humans, allow an extrapolation to the in vivo situation. This 
furthermore offers the unique possibility to reflect stages of lung diseases in a model 
relevant for the in vivo situation. 
Hypothesis 
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2 Hypothesis 
The reflection of aspects of COPD and acute lung injury/ARDS demands adequate in 
vitro and in vivo models that offer the capability to extrapolate the in vivo situation. In 
vitro models, however, lack organ complexity and in vivo animal models lack human 
physiology. A variety of 3D models were developed imitating organ and tissue function, 
but to date no lung tissue culture models have been described which can reflect the 
immune response in COPD and the lung destruction in acute lung injury/ARDS. 
Hypothesis of this doctoral thesis is that PCLS display a tissue model which reflects 
immunological and toxicological components of the lung diseases COPD and acute lung 
injury/ARDS, respectively. 
For proving this hypothesis, two different aspects were investigated: 
1. The potential of the organotypic lung model PCLS to provide a suitable model 
for mimicking the immune response in COPD was assessed. For this purpose, 
lung slices were exposed to the widely used model compound LPS, a component 
of gram-negative bacteria. Aim was to activate the innate immunity and to 
induce a prevailing immunological response by TLR4 ligation (Ishii et al., 
2008). Its immunological effects are based on the activation of NF-κB. 
Subsequently, an immediate release of cytokines such as TNF-α and IL-1β 
(Bailly et al., 1990) occurs which should reflect the release of pro-inflammatory 
mediators described in COPD. 
2. O3 and NO2 were applied to primarily induce toxicity of lung parenchyma which 
was already shown e.g. in vitro in epithelial cells (Ayyagari et al., 2004; Bakand 
et al., 2007) and which is described to be a main acute feature in acute lung 
injury/ARDS. The immunological response was expected to be weak. Very high 
concentrations of both gas compounds were used, since lung injury and 
toxication are associated with high-dose exposure to O3 (1–5 ppm) and NO2 
(100–500 ppm). A special issue of these exposures was the application of both 
gaseous compounds in an ALI culture – representing a physiologically relevant 
exposure with an unobstructed contact of lung tissue and chemical. 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
15 
3 Natural innate cytokine response to 
immunomodulators and adjuvants in human 
precision-cut lung slices 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
16 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
17 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
18 
 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
19 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
20 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
21 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
22 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
23 
 
 
 
 
 
 
Natural innate cytokine response to immunomodulators and adjuvants in human 
precision-cut lung slices 
24 
 
Legends for the Online Supplement 
 
 
Figure S1. Histopathological sections of lung tissue received from healthy trauma 
patient (A) and cancer patient (B). Illustrated are lung slices stained with 
hematoxylin/eosin and detected by light microscopy (magnification 20×). 
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Supplementary figure I. Image analysis of PCLS after 3 h of exposure to NO2. Lung 
slices were exposed to synthetic air (A) and 80 ppm NO2 (B) for 3 h at gas flow rate of 
10 mL/min followed by 21 h of submerged post-incubation. Tissue slices were stained 
with 4 µM calcein AM and 4 µM EthD-1, examined by confocal laser scanning 
microscopy and analyzed with IMARIS 5.5.3. Red colour shows cell nuclei (Ø 5 µm) of 
dead cells and green colour the cytoplasm of viable cells (grid spacing = 20 µm). 
 
Supplementary figure II. Image analysis of PCLS after 3 h of exposure to O3. Lung 
slices were exposed to synthetic air (A) and 8.5 ppm O3 (B) for 3 h at gas flow rate of 
10 mL/min followed by 21 h of submerged post-incubation. Tissue slices were stained 
with 4 µM calcein AM and 4 µM EthD-1, examined by confocal laser scanning 
microscopy and analyzed with IMARIS 5.5.3. Red colour shows cell nuclei (Ø 5 µm) of 
dead cells and green colour the cytoplasm of viable cells (grid spacing = 20 µm). 
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5 General discussion 
The data presented in this thesis addressed different functional issues: most importantly, 
the aim was to provide an ex vivo organotypic lung model which reflects immunological 
and toxicological aspects of the human lung diseases COPD and acute lung 
injury/ARDS, respectively. To this end, pro-inflammatory markers of the innate 
immune system in response to widely used model compound LPS were studied in 
human PCLS (publication: "Natural innate cytokine response to immunomodulators and 
adjuvants in human precision-cut lung slices"). Furthermore, O3 and NO2 were applied 
to primarily induce cytotoxicity in an ALI culture to mimic the acute toxicity in acute 
lung injury/ARDS. In this context, a physiologically relevant model should furthermore 
be established to enable unobstructed contact of the chemical and the lung tissue 
(publication: "Effects of acute in vitro exposure of murine precision-cut lung slices to 
gaseous nitrogen dioxide and ozone in an air-liquid interface (ALI) culture"). 
 
5.1 Reflection of the pro-inflammatory response in COPD in the 
organotypic lung model PCLS 
COPD as a lung disease with increasing prevalence in especially industrial countries is 
commonly caused by cigarette smoking with LPS as one important smoke component 
(Barnes et al., 2003; Hasday et al., 1999). Its function as an inducer of acute 
inflammation and neutrophil influx was supported by its capability to mimic the 
development of emphysema-like lesions and the cytokine profile of COPD – reasons 
why LPS is being widely used as a model compound (Brass et al., 2008; Hackett et al., 
2008, Savov et al., 2002). LPS itself derives from the cell wall of gram-negative 
bacteria and ubiquitous in the environment, e.g. in ambient aerosols (Heinrich et al., 
2003). Its highly conserved structure is a so-called pathogen-associated molecular 
pattern (PAMP) and provides the basis for its recognition by one of 13 already known 
toll-like receptors: TLR4 (Ishii et al., 2008; Kumar et al., 2009). In this process, a 
complex is built consisting of LPS itself, LPS-binding protein, and the cell surface 
glycoprotein CD14 (Chow et al., 1999). This complex subsequently binds to the 
extracellular leucin-rich repeated domain of TLR4 on various cell types such as DCs, 
Discussion 
37 
mast cells, eosinophils, monocytes, macrophages, B-cells, or epithelial cells, thereby 
initiating the intracellular NF-κB signaling (Iwasaki and Medzhitov, 2004; Takeuchi et 
al., 2001; Zhang et al., 2010). This signaling pathway and the resulting cytokine 
immune responses induced by LPS are highly organized, even when looking at lung 
diseases like COPD. This involves the release of multiple mediators including TNF-α, 
IL-1β, MCP-1, GM-CSF, and IL-8 (Barnes, 2004).  
A variety of cell cultures are used to study the release of cytokines as a response of the 
innate immunity to stimulation of different TLR like TLR3 and TLR4. In this context, 
bronchial epithelial cells such as BEAS-2B showed up-regulation of MIP-3α and GM-
CSF in response to LPS (Sha et al., 2004). They furthermore were used as an in vitro 
COPD model to investigate the role of LPS-induced expression of connective tissue 
growth factor (CTGF) (Nishioka et al., 2010). Human monocytes, human alveolar and 
bronchial epithelial cells lines, but also lung tissue explants released TNF-α, IL-1α, IL-
1β, IL-8, and IL-6 in response to LPS or cigarette smoke (Bailly et al., 1990; Hackett et 
al., 2008; Hellermann et al., 2002). Alveolar macrophages isolated from COPD patients 
are suitable to investigate anti-inflammatory effects of dexamethasone (Culpitt et al., 
1999). Single-cell cultures, however, are artificial systems that do not represent the 
complexity of the lung, in contrast to 3D in vitro models such as organotypic lung slices 
(Martin et al., 1996; Nassimi et al., 2009). They combine all immune and structural 
cells and allow the complex response to LPS to be studied. 
We established this human-based tissue model based on the production of cytokines in 
response to LPS to mimic the immunological response in COPD. Observations in 
COPD patients showed that increased amounts of cytokines such as TNF-α or IL-8 are 
produced compared to healthy subjects or healthy smokers (Aaron et al., 2001; Keatings 
et al., 1996). Animal models are often used to investigate features of COPD (Howard et 
al., 1993; Kaneko et al., 2007; Nadadur et al., 2005; Poynter et al., 2006). In these and 
similar studies, local inflammatory processes in the lung but also systemic outcomes 
were analyzed (Brass et al., 2008; Terashima et al., 1997). In general, however, COPD 
is a human-based disease that cannot fully be depicted in animals. For this reason, the 
focus of these models lies on the reflection of features of the disease such as early or 
chronic phases and their association with, e.g., the development of emphysema or the 
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production of pro-inflammatory mediators. Studies using mouse models observed 
elevation of the pro-inflammatory cytokines TNF-α, IL-1α, IL-1β, GM-CSF, RANTES, 
or MCP-1 using LPS and cigarette smoke as model compounds (Bracke et al., 2007; 
Van der Deen et al., 2007; Ogino et al., 2009; Vernooy et al., 2002). We could show 
that stimulation of human PCLS with LPS resulted in a significant increase in the same 
cytokines that were reported in the outcomes of COPD such as TNF-α, IL-1β, GM-CSF, 
RANTES, and MCP-1. The induced cytokine secretion observed in patients and after 
treatment with LPS are both based on activation of the signaling pathway NF-κB in a 
MyD88-dependent manner (Kumar et al., 2009; Hellerman et al., 2002). This NF-κB 
induction was shown to be dependent on TLR4 in both cases (Bihl et al., 2001; Doz et 
al., 2008). These data support the hypothesis that PCLS are suitable to display signaling 
pathways and the release of pro-inflammatory mediators which play an important role 
in the immunological response of COPD. 
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Figure 1: Signaling cascades induced in PCLS after treatment with model compounds 
LPS, NO2, O3, dexamethasone, and cigarette smoke.  
Abbreviations: LPS: Lipopolysaccharide, TLR: Toll-like receptor, TIR-domain: Toll/Interleukin-1 
receptor domain, MyD88: Myeloid differentiation primary response gene 88, NF-κB: Nuclear factor of 
kappa light polypeptide gene enhancer in B-cells, I-κB: NF-κB inhibitor beta, GR: Glucocorticoid 
receptor, HDAC: Histone deacetylase, NO2: Nitrogen dioxide, O3: Ozone, ROS: Reactive oxygen species, 
TNF-α:  Tumor necrosis factor alpha, IL-1: Interleukin 1, MCP-1: Monocyte-chemotactic protein-1, 
MIP-1β: Macrophage-inflammatory protein-1 beta, RANTES: Regulated on activation, normally T cell 
expressed and secreted, GM-CSF: Granulocyte/macrophage colony-stimulating factor 
 
 
 
In PCLS, treatment with dexamethasone successfully prevented LPS-induced 
production of pro-inflammatory cytokines and chemokines such as IL-1β, IFN-γ, GM-
CSF, and MCP-1 (figure 1). Tendencies for an inhibition could also be seen for 
RANTES or IL-10. Studies in macrophages, peripheral blood mononuclear cells 
(PBMCs), or whole blood showed similar results (Bhavsar et al., 2010; Giamarellos-
Bourboulis et al., 2010). Cytokines such as TNF-α, IL-1β, IL-10, and MIP-1β were 
clearly reduced by dexamethasone. This is based on the fact that corticosteroids inhibit 
the production of pro-inflammatory cytokines by recruiting histone deacetylase-2 
(HDAC), which furthermore suppresses the activation of cytokines (figure 1) by gene 
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silencing through deacetylation of DNA-bound histones. However, corticosteroids alone 
are nearly ineffective when used as a therapeutic drug in COPD (Culpitt et al., 1999; 
Culpitt et al., 2003; Keatings et al., 1997). There was no benefit in lung function, in cell 
counts, or in reduction of cytokines such as IL-8 and TNF-α in human studies. In 
COPD, permanent exposure to cigarette smoke induces strong oxidative stress which 
impairs the activity of histone deacetylases (figure 1), so that pro-inflammation and a 
destruction of lung alveoli are perpetuated (Barnes, 2004; Ito et al., 2001). Lung tissue 
additionally can be destroyed directly by free radicals released in response to cigarette 
smoke (Sun et al., 1995). The breakdown of connective lung tissue and the resulting 
degradation products such as hyaluronan from epithelial cells can furthermore act as 
ligands for TLR4 or TLR2 and enhance the inflammatory process (Jiang et al., 2006). It 
was already shown that one of the main differences between lung injury induced by 
LPS and cigarette smoke is the fact that LPS does not induce oxidative stress in a direct 
way (Valenca et al., 2008). While cigarette smoke which contains free radicals itself 
additionally induces superoxide dismutase, catalase, or neutrophil elastase (Shapiro et 
al., 2003; Valenca et al., 2008), LPS does not. These findings could be an explanation 
for the inhibitory function of dexamethasone in PCLS, which contradicts the in vivo 
situation. 
Contrary to the pro-inflammatory response of COPD that was successfully reflected in 
the established PCLS model, toxic feature that predominantly characterize acute lung 
injury/ARDS were subsequently analysed and discussed in comparison to models of 
lung injury and endotoxemia. 
 
5.2 PCLS mimic early toxic features of acute lung injury/ARDS 
Acute lung injury/ARDS is mainly characterized by a diffuse damage of lung 
parenchyma induced, e.g., by inhalation of toxic agents or smoke. Edema and increased 
permeability in endothelial cells and type I pneumocytes occur within hours. For 
depicting cellular damage in acute lung injury/ARDS the irritant gas compounds O3 and 
NO2 have been widely used as model compounds. Both agents are common air 
pollutants which have been described to be associated with exacerbations of lung 
diseases such as bronchial asthma (Bayram et al., 2001; Hiltermann et al., 1995; Jenkins 
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et al., 1999). But most importantly, both gas compounds cause acute toxic effects in the 
airways as have been described for acute lung injury/ARDS, in particular when 
administered at high doses. 
In vivo studies in rhesus monkeys showed increased necrotic airway epithelial cell death 
after exposure to 0.8 ppm O3, with injured epithelial cells being removed by immigrated 
neutrophils (Hyde et al., 1999). Additionally, a close association between the O3 dose, 
the degree of epithelial injury, and glutathione depletion could be shown (Plopper et al., 
1998). High toxic doses ranging from 2 ppm to 5 ppm induced immediate toxicity in 
rats, which was furthermore supported by gene array analysis in rats and alveolar type II 
cells derived from rats (Nadadur et al., 2005; Wang et al., 2006). Besides apoptotic 
proteins like growth arrest and DNA-damage inducible 45 alpha, stress proteins such as 
heat shock proteins but also antioxidants like glutathione S transferase and superoxide 
dismutase were additionally up-regulated.  
The association of toxicity and epithelial lung disruption has been widely studied in in 
vitro models of inhalation injury. To this end, O3- and NO2-induced cytotoxicity was 
investigated, e.g., in A549, NHBE cells, HeLa cells, THP-1 cells, and HUVE cells 
(Ahmad et al., 2005; Ayyagari et al., 2007; Bakand et al., 2006; Brink et al., 2008; 
Fakhrzadeh et al., 2004; Tu et al., 1995). The background of the toxic effects that are 
induced by gas compounds are occurring necrosis and apoptosis. Kinetics revealed 
caspase-3-independent apoptotic cell death during the early period after exposure to 
NO2. However, necrotic cell death occurred prevalently at later time points (Ayyagari et 
al., 2007). In this context, generated nitric oxides (NO) were shown to be involved. 
Besides extracellular damage like that of epithelial cells, intracellular damage of DNA 
was found (Brink et al., 2008). Different mechanisms which are responsible for toxicity 
exist, such as induction of oxidative stress through production of ROS such as 
peroxynitrite, nitric oxides, or superoxides (Fakhrzadeh et al., 2004; Klestadt et al., 
2002; Laskin et al., 2001). In this context, lipid peroxidation occurs mainly based on 
ROS which directly attack either cellular membrane lipids or circulating lipoprotein 
molecules, leading to cytotoxicity. This could be shown in human studies investigating 
the association of short- and long-term exposure with induced oxidative stress and lipid 
peroxidation (Chen et al., 2007).  
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In PCLS, treatment for 3 hours with NO2 and O3 resulted in toxic effects. In particular, 
the highest concentrations used, reaching 80 ppm for NO2 and 8.5 ppm for O3, induced 
cell death. Vitality staining revealed an elevated number of stained dead nuclei and 
decreased esterase activity indicated by lacking calcein staining. Apart from lipid 
peroxidation through which membrane lipids are directly disrupted, free radicals are 
also able to activate pro-inflammatory mediators by degrading the IκBα subunit, 
resulting in constitutive expression of NF-κB (Bar-Shai and Reznick, 2006; Bar-Shai et 
al., 2008). As described, toxic events can also be triggered by pro-inflammatory 
mediators (Shimabukuro et al., 2003). In this case, cytokines such as TNF-α, IFN-γ, and 
IL-6 exacerbate O3- and NO2-induced cytotoxicity (Ayyagari et al., 2004; Cho et al., 
2001; Fakhrzadeh et al., 2004; Johnston et al., 2005). The pro-inflammatory cytokine 
IL-1 plays an important role in the early phase after exposure to O3, which is initiated 
after 2 to 24 hours (Leikauf et al., 1995), but it was also described to be involved in 
toxic events leading to lung leakage. Similar results could be shown for cytokines such 
as MCP-1 and MIP-1β (Leikauf et al., 1995; Zisman et al., 1997). One underlying 
mechanism is the extrinsic pathway which is based on the binding of, e.g., the pro-
inflammatory cytokine TNF-α to its death receptor TNF-R1 possessing a death domain. 
Subsequently, apoptosis is induced by this complex and procaspase 8 (Galani et al., 
2010). 
Exposure to both gas compounds induced cytotoxicity in PCLS, but only exposure to O3 
induced an early release of IL-1α and a tendency for RANTES. Cytokines such as 
eotaxin, IL-8, or granulocyte colony-stimulating factor (G-CSF) were not induced. This 
was also shown for concentrations of up to 100 ppb O3 in bronchial epithelial cell 
cultures (Bayram et al., 2001) or rat NR8383 alveolar macrophage cultures (Manzer et 
al., 2008). Exposure to NO2 resulted in a dose-dependent production of pro-
inflammatory IL-1α (40%), whereas RANTES, IL-12, and eotaxin remained 
unchanged. In acute lung injury/ARDS toxicity of epithelial and endothelial cells is a 
dominating process, although production of cytokines could be demonstrated (Galani et 
al., 2010). In this context, release of, e.g., the pro-inflammatory cytokine IL-1, which 
was also detected in PCLS after exposure to O3, increases chemotaxis of neutrophils, 
diminishes apoptosis of activated neutrophils, and subsequently supports the ongoing 
destruction of structural cells. 
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PCLS turned out to be a suitable organotypic model to reflect lung diseases. Its 
relevance for the in vivo situation is a critical point and has to be assessed and discussed 
in the context of further complex established models.  
 
5.3 Status of the development of organ complexity of organo-
typic cell- and tissue-based 3D-models 
The evaluation of cellular complexity and structural integrity has been widely used over 
at least two decades. At this, physiological models were developed to mimic organ and 
tissue function in a 3D arrangement as it was shown for capillaries or mammary glands 
(Enami and Nandi, 1977; Ingber and Folkman, 1989). The most simplistic model was 
the application of single or immortalized cells with tissue-specific differentiated 
functions. Cells were embedded on membranes to study, e.g., adhesion of fibroblasts, 
type II pneumocyte function and morphology, or induction of apoptosis in breast cell 
lines (Cukierman et al., 2001; Kirshner et al., 2003; Rannels et al., 1987). These models 
approximated tissue-specific function, but did not comprise different cell types as they 
are present in an organ. The reflection of, e.g., apoptosis induced by adhesion molecules 
can be studied in single cells, but the impact of apoptosis-regulating cell types including 
NK cells and CD8+ T cells on affected cells cannot be analyzed (Kirshner et al., 2003; 
Smyth et al., 2005). For this reason, 3D-organotypic co-cultures constituted the next 
step in the development. In epidermal biology, 3D models have been successfully 
developed by culturing epidermal cell suspensions on dermis or on fibroblasts 
(Prunieras et al., 1983; Bell et al., 1981). In inhalation toxicology, 3D co-culture models 
were used to simulate the respiratory tract. Macrophages, epithelial cells, and DCs were 
analysed in a triple model to study the outcomes of exposure to polystyrene particles 
(Rothen-Rutishauser et al., 2005; Brandenberger et al., 2010). Furthermore, dissociated 
lung cells were cultured on Matrigels to study rearrangement and polarization of lung 
cells (Schuger et al., 1990; Schuger et al., 1996). But none of these models reflects the 
individuality and function of a complete organ which is based on the surrounding 
environment like the extracellular matrix and neighbouring cell interactions. 
Consequently, tracheal ring preparations, isolated perfused lungs, or lung parenchymal 
strips were developed for the analysis of, e.g., smooth muscle function (de Jongste et 
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al., 1985; Jongejan et al., 1990; Finney et al., 1985; Wang et al., 1992). However, the 
responses of parenchymal strip preparations were not consistent between different 
species and not even within one animal (Finney et al., 1985; Ghelani et al., 1980). In 
contrast, the lung tissue model PCLS possesses a uniform thickness of 250 µm due to 
precise slicing by the Krumdieck Tissue Slicer, which can be provided for almost all 
species. The presence of the relevant structure and architectural organization is 
supported by the manifold cells, their cell-cell and cell-matrix interactions as shown by 
smooth muscle and airway contractions, or by staining of antigen-presenting cells 
(Bergner and Sanderson, 2002a; Cooper et al., 2009; Henjakovic et al., 2008). But 
neither PCLS nor one of the previously mentioned models can overcome the 
discrepancy of the missing blood or lymphatic circulation. Despite the lack of 
immigrating cells, they possess a complex and organ-relevant structure. But relevant 
and complex organotypic models, however, should not only imply the possibility to 
study complex immune responses induced in different cells simultaneously; relevant 
organotypic models are required to cover another main aspect: measured responses have 
to be physiologically relevant and have to reflect the in vivo situation. 
 
5.4 Assessment of in vivo relevance of PCLS 
Finally, the conditions for complexity of the organ are confirmed in PCLS; but to assess 
the in vivo relevance of the lung slices it was necessary to compare and correlate the 
data obtained by using PCLS with already known data from human studies. To this end, 
data from a clinical study performed by Schaumann et al., 2008 were utilized in a linear 
regression analysis model. Twelve cytokines including TNF-α, IL-1α, MIP-1β, IL-10, 
GM-CSF, and RANTES from bronchoalveolar lavage (BAL) fluid from subjects who 
had undergone segmental instillation of 2 ng endotoxin were correlated with data from 
human PCLS. The calculated coefficient of correlation was 0.931, indicating high 
resemblance and high relevance to the in vivo situation. Nevertheless, careful 
consideration is necessary here, given that the lung tissue for the generation of PCLS 
was received from cancer patients.  
For the relevance of a model it is not only important to have a system that imitates the 
in vivo situation of the immune response very closely, but the uptake of a chemical or a 
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drug also has to resemble the in vivo exposure. In general, airway epithelial cells are the 
first line of defense in the lung. Their barrier function is supported by the secretion of 
mucins (Girod et al., 1992), surfactant (Hohlfeld et al., 1997), and anti-microbial 
peptides such as defensins or lysozymes (Schnapp and Harris, 1998). Furthermore, 
macrophages and DCs take up antigens for presentation. Subsequently, these are the 
first cells and molecules that get in contact with inhaled antigens. The unobstructed 
exposure of insoluble compounds such as gaseous compounds or particles has been the 
subject of various toxicological in vitro studies using different experimental setups. 
Some of these included submerged cultures with the test gas being directed over the 
adherent cells by shaking them at certain angles, so that the cells alternated between 
exposure and immersion in the culture medium (Bion et al., 2002; Bombick et al., 1998; 
Rusznak et al., 1996). Others passed the gas over the cell suspension (Ayyagari et al., 
2007). Submerged exposure conditions, however, always lead to intensive mixing of the 
test gas and the culture medium. In this case, the gaseous compound such as O3 reacts 
with components of the culture medium and is very effectively hindered from reaching 
the cells. The ALI culture exposure model we used, performed with O3 and NO2 in 
PCLS, in the future might offer new insights into effects induced by airborne or inhaled 
chemicals which up to date have only been studied under conditions that do not 
resemble the in vivo uptake of antigens. 
In conclusion, the obtained results indicated that organotypic lung model PCLS 
approaches the in vivo situation very closely and most importantly it displays a suitable 
model to reflect immunological responses of COPD and toxic aspects of acute lung 
injury/ ARDS. 
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6 Outlook 
By means of the presented data it could be shown that PCLS provide a suitable model to 
reflect the immunological response of COPD. One main characteristic of COPD, 
however, is its unresponsiveness to corticosteroids which generally inhibit a pro-
inflammatory immune response. LPS-induced pro-inflammatory mediators could be 
inhibited in PCLS by the synthetic corticosteroid dexamethasone, thus contradicting the 
in vivo situation. One of the main limitations of the LPS-induced COPD model is the 
lacking oxidative stress that was described after contact to cigarette smoke. 
Consequently, PCLS should be exposed to cigarette smoke to deliver a more relevant 
COPD-model. For direct quantification of oxidative stress, the amounts of glutathione 
should be determined in PCLS. In a cigarette smoke-induced COPD model, co-
treatment with dexamethasone should fail in reducing the cigarette smoke-induced pro-
inflammatory response of PCLS. Roflumilast, a PDE-4 inhibitor which is actually 
successfully used as a therapeutic drug in COPD, could additionally be used for co-
exposure with cigarette smoke, expected to prevent the pro-inflammatory response. But 
cigarette smoke also contributes to DNA fragmentation as one risk factor for cancer. 
Such a fragmentation could be quantified by using a comet assay.  
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8 List of abbreviations 
 
ALI Air-liquid interface  
AP-1 Activator protein-1 
ARDS Acute respiratory distress syndrome 
ATP Adenosine triphosphate 
BAES-2B Human bronchial epithelial cell line 
BAL Bronchoalveolar lavage 
B cell Bone marrow cell 
CD Cluster of differentiation 
COPD Chronic obstructive pulmonary disease 
CTGF Connective tissue growth factor 
DC  Dendritic cell 
DNA Deoxyribonucleic acid 
ERK Extracellular signal-regulated kinase 
G-CSF Granulocyte colony-stimulating factor 
GM-CSF Granulocyte/macrophage colony-stimulating factor 
GOLD Global initiative for chronic obstructive lung disease 
GR Glucocorticoid receptor 
H2O2  hydrogen peroxide 
HBEC Human bronchial epithelial cell line 
HDAC Histone deacetylase  
HeLa cell Human epithelial cervical cancer cell 
HUVE cell Human umbilical vein endothelial cell 
IFN-γ Interferon-gamma 
IκBα Inhibitor of NF-κB 
IL Interleukin 
LFA-1 Leukocyte function associated antigen-1 
LPS Lipopolysaccharide 
MAPK Mitogen-activated protein kinase 
MCP-1 Monocyte-chemotactic protein-1 
MHC Major histocompatibility complex 
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MIF4 Macrophage migration inhibitory factor 4 
MIP-1β Macrophage-inflammatory protein-1 beta 
MODS Multiple organ dysfunction syndrome 
MOF Multiple organ failure 
MyD88 Myeloid differentiation primary response gene (88) 
NF-κB Nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
NHBE cell Normal human bronchial epithelial cell 
NK cell Natural killer cell 
NO nitric oxides 
NO2 Nitrogen dioxide 
NOS Nitrogen species 
O2 −  superoxide anion  
O3 Ozone 
PAMP Pathogen-associated molecular pattern 
PBMC peripheral blood mononuclear cell 
PCLS Precision-cut lung slices  
Ppm parts per million 
RANTES Regulated on activation, normally T cell expressed and secreted 
ROS Reactive oxygen species 
SIRS Systemic inflammatory response syndrome 
SOD Superoxide dismutase 
STAT Signal transducer and activator of transcription 
T cell Thymus cell 
TH cell T helper cell 
THP-1 cell Human monocyte leukemia cell line 
TIR Toll/IL-1R  
TLR Toll-like receptor 
TNF-α Tumor necrosis factor alpha 
TNF-R Tumor necrosis factor receptor 
VLA Very-late-antigen-4 
WHO World Health Organization 
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